The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out
- PMID: 34197767
- PMCID: PMC8238445
- DOI: 10.1016/S1473-3099(21)00356-X
The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out
Conflict of interest statement
AC reports grants from NIHR, Asthma UK, Boehringer-Ingelheim Charity; consulting fees and honoraria from Sanofi; and support for meeting attendance from GSK. All other authors declare no competing interests.
Comment on
-
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.Lancet Infect Dis. 2021 Sep;21(9):1246-1256. doi: 10.1016/S1473-3099(21)00170-5. Epub 2021 Apr 12. Lancet Infect Dis. 2021. PMID: 33857406 Free PMC article.
References
-
- Frampton D, Rampling T, Cross A, et al. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00170-5. published online April 12. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous